
Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial
Publication
, Conference
Wang, C; Teer, J; Yao, J; Carmen, AGM; Noyes, D; Toloza, E; Mullinax, J; Landin, A; Gray, J; Tanvetyanon, T; Saltos, A; Kelley, L; Fang, B ...
Published in: JOURNAL FOR IMMUNOTHERAPY OF CANCER
November 6, 2019
Duke Scholars
Published In
JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN
2051-1426
Publication Date
November 6, 2019
Volume
7
Publisher
BMC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, C., Teer, J., Yao, J., Carmen, A. G. M., Noyes, D., Toloza, E., … Creelan, B. (2019). Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 7). BMC.
Wang, Chao, Jamie Teer, Jiqiang Yao, Anadon Galindo M. Carmen, David Noyes, Eric Toloza, John Mullinax, et al. “Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 7. BMC, 2019.
Wang C, Teer J, Yao J, Carmen AGM, Noyes D, Toloza E, et al. Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial. In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.
Wang, Chao, et al. “Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial.” JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 7, BMC, 2019.
Wang C, Teer J, Yao J, Carmen AGM, Noyes D, Toloza E, Mullinax J, Landin A, Gray J, Tanvetyanon T, Saltos A, Kelley L, Fang B, Koomen J, Sarnaik A, Kim S, Pilon-Thomas S, Conejo-Garcia J, Antonia S, Haura E, Creelan B. Clinical response to Tumor Infiltrating Lymphocytes (TIL) in stage 4 Non-small Cell Lung Cancer (NSCLC) correlates with Neoantigen-Specificity: a phase I trial. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.

Published In
JOURNAL FOR IMMUNOTHERAPY OF CANCER
ISSN
2051-1426
Publication Date
November 6, 2019
Volume
7
Publisher
BMC
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology